AU2003264030A8 - Improved method to identify targeting molecules - Google Patents

Improved method to identify targeting molecules

Info

Publication number
AU2003264030A8
AU2003264030A8 AU2003264030A AU2003264030A AU2003264030A8 AU 2003264030 A8 AU2003264030 A8 AU 2003264030A8 AU 2003264030 A AU2003264030 A AU 2003264030A AU 2003264030 A AU2003264030 A AU 2003264030A AU 2003264030 A8 AU2003264030 A8 AU 2003264030A8
Authority
AU
Australia
Prior art keywords
improved method
targeting molecules
identify targeting
identify
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264030A
Other versions
AU2003264030A1 (en
Inventor
Elias Lazarides
Xiao-Min Fan
Catherine Mary Woods
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Targeted Molecules Corp
Original Assignee
Targeted Molecules Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Molecules Corp filed Critical Targeted Molecules Corp
Publication of AU2003264030A8 publication Critical patent/AU2003264030A8/en
Publication of AU2003264030A1 publication Critical patent/AU2003264030A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003264030A 2002-08-08 2003-08-08 Improved method to identify targeting molecules Abandoned AU2003264030A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40237202P 2002-08-08 2002-08-08
US60/402,372 2002-08-08
US74092703P 2003-05-14 2003-05-14
PCT/US2003/024994 WO2004015392A2 (en) 2002-08-08 2003-08-08 Improved method to identify targeting molecules
US60/740,927 2005-11-30

Publications (2)

Publication Number Publication Date
AU2003264030A8 true AU2003264030A8 (en) 2004-02-25
AU2003264030A1 AU2003264030A1 (en) 2004-02-25

Family

ID=31720595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264030A Abandoned AU2003264030A1 (en) 2002-08-08 2003-08-08 Improved method to identify targeting molecules

Country Status (4)

Country Link
EP (1) EP1542733A2 (en)
AU (1) AU2003264030A1 (en)
CA (1) CA2494551A1 (en)
WO (1) WO2004015392A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060036476A (en) * 2003-08-08 2006-04-28 가부시키가이샤 티슈 타겟팅 쟈판 Polypeptides having brain-disposition activity and utilization of the same
US20090092583A1 (en) * 2005-08-26 2009-04-09 Makoto Sawada Brain-localizing cells and uses thereof
FR2957597A1 (en) * 2010-03-17 2011-09-23 Univ Picardie SYNTHETIC CYCLOPEPTIDES, PROCESS FOR PREPARATION AND USES
CN108484640B (en) * 2018-05-22 2020-09-15 南京华威医药科技集团有限公司 Anti-tumor apoptosis protein inhibitor
WO2024042466A1 (en) * 2022-08-22 2024-02-29 University Of Tartu Brain penetrating peptides and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684621A (en) * 1984-11-21 1987-08-04 Smithkline Beckman Corporation Methods of producing vasodilation or antioxytocic activity
US5622699A (en) * 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo
AU4412297A (en) * 1996-09-10 1998-04-02 Burnham Institute, The Tumor homing molecules, conjugates derived therefrom, and methods of using sa me

Also Published As

Publication number Publication date
WO2004015392A2 (en) 2004-02-19
CA2494551A1 (en) 2004-02-19
WO2004015392A3 (en) 2004-07-29
AU2003264030A1 (en) 2004-02-25
EP1542733A2 (en) 2005-06-22

Similar Documents

Publication Publication Date Title
SI2415577T1 (en) Methods to produce gel sheets
GB0304799D0 (en) Novel method
EP1511408A4 (en) Cross reference to related art
IL152746A0 (en) Biosensor for molecules
AU2003275254A8 (en) Targeted cd1d molecules
GB0201864D0 (en) Improvements relating to pipelines
GB0328363D0 (en) Therapeutically useful molecules
GB0304726D0 (en) New Process
GB0317229D0 (en) Improved process
AU2003264030A8 (en) Improved method to identify targeting molecules
PT1857547T (en) Further novel forms of interfering rna molecules
EP1620840A4 (en) Improvements relating to billboards
GB0325055D0 (en) New process
AU2003230760A8 (en) Lipid-associated molecules
AU2003273258A8 (en) Process to prepare psorospermin
GB0516602D0 (en) Pantolactone hydrolase
GB0308696D0 (en) New process
ITMI20021432A1 (en) METHOD TO PRODUCE CEPHALOSPORINE
GB0306185D0 (en) Molecules
GB0209619D0 (en) Molecules
GB0211232D0 (en) Molecules
GB0311317D0 (en) Molecules
GB2405594B (en) Improvements relating to nebulisers
GB0215482D0 (en) Improvements relating to game-show apparatus
GB0320661D0 (en) Improvements relating to information processing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase